Comments
Bengaluru-based maternity care hospital chain Cloudnine will enter into preventive health management for women in a year. The hospital will invest in genetic profiling and other technology for women wellness.
The company has invested in Transmural Biotech, a Spanish company, for early screening of breast cancer.
In addition, the hospital will invest ₹400 crore to develop seven hospitals in Bengaluru, Delhi, Mumbai and Chandigarh by June 2018. An additional ₹150 crore will be spent on strengthening the Chennai market and expanding to newer markets such as Kochi, Visakhapatnam and Coimbatore.
Of the ₹350 crore turnover, mother and child care account for about 80 per cent and the rest comes from fertility and paediatric care.
Neonatal care demandNitin Nag, Regional Director, Cloudnine Group of Hospitals, told BusinessLine that the chain is witnessing increasing demand for neonatal facilities in India. Investments in increasing capacity and resources to take care of newborn babies have increased over the years.
Around four in every 200 deliveries result in complications. But many hospitals in India lack a dedicated facility such as neonatal intensive care unit to handle complications and physicians specialised in neonatal care . “So, we collaborate with other hospitals and share the facility on need basis,” Nag said.
The chain has partnered with 70 hospitals across the country. Nag said, “There are times when we have more babies from other hospitals in the unit than in-house babies.”
Rising infertility
Another contributing factor to the demand for neonatal care is late childbirth due to late marriages and rising infertility. In recent times, late marriages have become a norm and this has resulted in late motherhood.
A number of people undergoing fertility treatment have also increased due to urban lifestyle, unhealthy food habits and more focus on career.
Nag said, “Around 15 per cent of Indian population suffer from fertility issues. Earlier, people who seek fertility treatment were in the age group 27 to 35. Now, we are seeing people between 23 and 31 years coming for fertility treatment.”
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.